Micropharm

Develops and manufactures polyclonal antibody medicines, including antivenoms, for healthcare markets

Newcastle Emlyn, United KingdomFounded 1998micropharm.co.ukWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-30

About Micropharm

Micropharm develops and manufactures targeted polyclonal antibody therapeutics for infectious diseases and acute toxic events. Its commercial products include antivenoms for human use; its development pipeline includes an oral antibody drug for Clostridioides difficile infection and additional polyvalent antivenoms.

The company sells antivenoms in Europe, the Caribbean and West Africa. Manufacturing covers serum and plasma purification, formulation, sterile filling and packaging.

Founded in 1998, Micropharm is headquartered in Newcastle Emlyn and operates two manufacturing sites in West Wales licensed by the UK Medicines and Healthcare products Regulatory Agency.

Product: Develops and manufactures polyclonal antibody therapeutics, including human antivenoms and products in development for infectious diseases.

Jobs at Micropharm

No open positions listed right now.

More biotech & pharma companies

  • Midland Pharmaceuticals

    Clinical-stage therapeutics for spinal cord injury and ischemic stroke patients
    London, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc
  • Mission Therapeutics

    Develops small-molecule deubiquitylating enzyme (DUB) inhibitors for Parkinson's and other serious diseases, alone and with pharma partners
    Cambridge, United KingdomBiotech & pharmaFounded 2011
    New on Evolc
  • Moolec Science

    Produces animal proteins and plant-based ingredients in crops such as soybean and safflower for food companies worldwide
    Warwick, United KingdomBiotech & pharmaFounded 2020
    New on Evolc
  • Myricx Pharma

    Develops antibody-drug conjugate cancer therapies using payloads based on N-myristoyltransferase inhibitors
    London, United KingdomBiotech & pharmaFounded 2019
    New on Evolc
  • Neurolieve Biosciences

    Developing a non-opioid biologic for patients with neuropathic pain, designed to relieve pain and support nerve regeneration
    London, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc
  • Nexus Bioquest

    Immunology CRO running custom assays and pre-clinical drug discovery studies for pharma and biotech teams
    London, United KingdomBiotech & pharmaFounded 2022
    Young companyNew on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • LiteSpeed
  • WordPress